{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T23:48:48Z","timestamp":1775951328469,"version":"3.50.1"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":48,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.idcr.2026.e02524","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T08:17:30Z","timestamp":1771489050000},"page":"e02524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Bilateral optic neuropathy following prolonged linezolid use: A case report"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0447-0132","authenticated-orcid":false,"given":"Hadiza Ometere","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaesha Easa","family":"Alnuaimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amani","family":"Alzaabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahfoud","family":"Elbashari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Abouelnaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amna","family":"Almaazmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.idcr.2026.e02524_bib1","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1021\/jm800038g","article-title":"Linezolid (ZYVOX), the first member of a new class of antibacterials: oxazolidinones","volume":"51","author":"Brickner","year":"2008","journal-title":"J Med Chem"},{"issue":"8","key":"10.1016\/j.idcr.2026.e02524_bib2","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1086\/501356","article-title":"Linezolid-induced inhibition of mitochondrial protein synthesis","volume":"42","author":"De Vriese","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idcr.2026.e02524_bib3","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1128\/AAC.01190-06","article-title":"Reversible inhibition of mitochondrial protein synthesis during linezolid-related hyperlactatemia","volume":"51","author":"Garrabou","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.idcr.2026.e02524_bib4","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1212\/01.wnl.0000201313.24970.b8","article-title":"Linezolid-associated toxic optic neuropathy","volume":"66","author":"Rucker","year":"2006","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.idcr.2026.e02524_bib5","first-page":"356","article-title":"Clinical characteristics and prognosis of toxic optic neuropathy associated with linezolid","volume":"42","author":"Choi","year":"2022","journal-title":"J Neuroophthalmol"},{"issue":"9","key":"10.1016\/j.idcr.2026.e02524_bib6","article-title":"Long-term linezolid therapy and mitochondrial toxicity: clinical implications","volume":"64","author":"Chen","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.idcr.2026.e02524_bib7","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/cid\/ciaa1125","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA guideline","volume":"71","author":"Daley","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idcr.2026.e02524_bib8","first-page":"1085","article-title":"Association between linezolid use and optic neuropathy: a pharmacovigilance study","volume":"85","author":"Morales","year":"2019","journal-title":"Br J Clin Pharm"},{"key":"10.1016\/j.idcr.2026.e02524_bib9","first-page":"98","article-title":"Linezolid-induced optic neuropathy: clinical features and outcomes","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Ophthalmol"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250926000375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250926000375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T23:11:10Z","timestamp":1775949070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250926000375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":9,"alternative-id":["S2214250926000375"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2026.e02524","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bilateral optic neuropathy following prolonged linezolid use: A case report","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2026.e02524","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e02524"}}